• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Tolerance induction against hepatic ischemia/reperfusion injury by an artificial regulation of the intracellular signal

Research Project

Project/Area Number 16591288
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionAkita University

Principal Investigator

KUME Makoto  Akita University, School of Medicine, Assistant, 医学部, 助手 (00372326)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Yuzo  Akita University, School of Medicine, Professor, 医学部, 教授 (70281730)
SATO Tsutomu  Akita University, School of Medicine, Associate Professor, 医学部, 助教授 (90235367)
Project Period (FY) 2004 – 2005
Keywordshepatic ischemia / reperfusion injury / cyclic AMP / protein kinase A / phosphodiesterase-3 inhibitor / liver transplantation
Research Abstract

Aim. The purpose of this study was to determine the influence of PKA on the hepatoprotective effect of milrinone on warm ischemia-reperfusion (I/R) injury of rat livers.
Methods. Male Lewis rats were randomly allocated into three groups. Group A : Milrinone was administrated continuously i.v. at 5 μg/kg/min for 10 min, then 0.5 μg/kg/min for 10 min. Group B : PKA inhibitor Rp-8-Br-cAMPS was injected prior to milrinone administration. Group C : control without pre-treatment. Then, all animals were exposed to a 45-min hepatic warm ischemia by Pringle's maneuver. Concentration of cAMP in the liver tissue before ischemia was measured by enzyme immunoassay. PKA activity was measured by kinaseassay, andtheactivity was quantified as active PKA / total PKA ratio. I/R induced liver damage was quantified by serum ALT at 6 hours of reperfusion. Survival rate were compared on the 7^<th> postoperative day.
Results. Tissue cAMP concentration was significantly elevated in group A and B than that of group C
(A: 2.8 ± 0.2, B: 3.0 ± 0.2, C: 2.2 ± 0.2 (pmol/mg protein)). PKA inhibitor effectively suppressed PKA activity ratio after a milrinone treatment (A: 28.7 ± 5.0, B: 19.8 ± 1.9, C: 20.2 ± 2.5 (%)). In
group A, ALT level was well suppressed and the survival rate was significantly better than
in group C. Despite the elevated level of cAMP, elevated ALT level after reperfusion was significantly higher and survival rate was significantly lower in group B than in group A. ALT ; A; 1302 ± 387, B; 2590 ± 378 and C; 2889 ± 1306 (U/L), survival ; A: 15/16, B: 9/16, C: 9/16, (p <0.05).
Conclusion. PKA dependent signal pathway is a key structure element in the acquisition of ischemic tolerance of the liver by milrinone.

  • Research Products

    (6 results)

All 2006 2005

All Journal Article (6 results)

  • [Journal Article] 肝臓機能保護とプレコンディショニング2006

    • Author(s)
      山本 雄造
    • Journal Title

      臨床病理 54・1

      Pages: 59-66

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Preconditioning and functional preservation of the liver2006

    • Author(s)
      Yuzo, YAMAMOTO
    • Journal Title

      Rinshoubyouri 54-1

      Pages: 59-66

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] 肝細胞癌2005

    • Author(s)
      久米 真
    • Journal Title

      外科治療 92・3

      Pages: 266-271

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] 肝における熱ショック蛋白質の発現と機能2005

    • Author(s)
      打波 宇
    • Journal Title

      G. I. Research 13・6

      Pages: 442-448

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Hepatocellular carcinoma2005

    • Author(s)
      Makoto KUME, et al.
    • Journal Title

      Geka-chiryou 92-3

      Pages: 266-271

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Induction and function of heat shock proteins in the liver2005

    • Author(s)
      Hiroshi, UCHINAMI, et al.
    • Journal Title

      G.I.Research 13-6

      Pages: 442-448

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2007-12-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi